BROADCASTS.com

b'My guest today is D.A. Wallach, one of the more interesting investors I\\u2019ve come across. He is the former lead singer of the group Chester French and the former artist-in-residence at Spotify, where he was also an early investor. While he\\u2019s also an early investor in companies like SpaceX, his focus the last 5 years has been on early stage health care investing, which is the topic of this conversation. We discuss the entire life sciences and heath care investing ecosystem. This was recorded in the very early days of the Coronavirus outbreak so while we touch on it briefly it isn\\u2019t the primary focus, and I intend on returning to more traditional episodes like this one in the coming weeks, meant to be evergreen conversations. Please enjoy my conversation with D.A. Wallach.\\n For more episodes go to InvestorFieldGuide.com/podcast.\\n Sign up for the book club, where you\\u2019ll get a full investor curriculum and then 3-4 suggestions every month at InvestorFieldGuide.com/bookclub.\\n Follow Patrick on Twitter at @patrick_oshag\\n \\xa0\\n Show Notes\\n 1:31 \\u2013 (First question) \\u2013 Where is interest in healthcare started\\n 4:04 \\u2013 How to categorize health services\\n 5:13 \\u2013 The product of medicine\\n 6:56 \\u2013 How medicine is changing in 2020\\n 10:17 \\u2013 What is enabling innovation in medicine\\n 12:41 \\u2013 Manufacturing of solutions, gene therapy example\\n 17:16 \\u2013 Using CRISPR\\n 19:47 \\u2013 Pros and cons, and the morality of gene intervention\\n 23:44 \\u2013 How progress is being made in medical breakthroughs\\n 26:51 \\u2013 What is the business and investment world seeing on the longevity side\\n 30:15 \\u2013 What is next in the wearable medical tracking trend\\n 33:04 \\u2013 The personalization of medical treatments\\n 34:31 \\u2013 How he thinks about all of this from an investing standpoint\\n 36:37 \\u2013 Exiting these companies\\n 39:41 \\u2013 How he thinks about founders in this space\\n 42:35 \\u2013 Drug prices\\n \\xa0\\xa0\\xa0\\xa0\\xa0\\xa0\\xa0\\xa0\\xa0\\xa0\\xa0 42:46 \\u2013 The Paradox of Pricing\\n 46:45 \\u2013 What will lead to a change in the pricing of drugs\\n 49:05 \\u2013 The delivery side of healthcare\\n 51:09 \\u2013 Investments that could improve the delivery side of healthcare\\n 53:33 \\u2013 Thoughts on the anti-interventionist line of thinking in the medical world\\n 57:50 \\u2013 Lessons from his health portfolio\\n 1:02:33 \\u2013 Other frontiers that pique his interest, including gut biome\\n 1:06:46 \\u2013 His career in music\\n 1:08:20 \\u2013 Lessons he learned during his time in the music industry\\n 1:10:19 \\u2013 Opportunities in the music industry as an investor\\n 1:12:29 \\u2013 Kindest thing anyone has done for DA\\n \\xa0\\n Learn More\\n For more episodes go to InvestorFieldGuide.com/podcast.\\xa0\\n Sign up for the book club, where you\\u2019ll get a full investor curriculum and then 3-4 suggestions every month at InvestorFieldGuide.com/bookclub\\n Follow Patrick on Twitter at @patrick_oshag'